Clinical utility of long-term enalapril/diltiazem ER in stage 3-4 essential hypertension

Journal of Clinical Pharmacology

Volumn 37, Issue 9, 1997, Pages 810-815

  Chrysant, Steven G ^a   Gavras, Haralambos ^b   Niederman, Alan L ^c   Marbury, Thomas C ^d   Goldstein, Robert ^d  

^a UNIVERSITY OF OKLAHOMA   (United States)

^b BOSTON UNIVERSITY MEDICAL CENTER   (United States)

^c Heart Group Research   (United States)

^d ORLANDO CLINICAL RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; HYDROCHLOROTHIAZIDE; METHYLDOPA;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; ESSENTIAL HYPERTENSION; FACE EDEMA; FEMALE; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION;

EID: 0030808674     PISSN: 00912700     EISSN: None     Source Type: Journal    
DOI: 10.1002/j.1552-4604.1997.tb05628.x     Document Type: Article

References (22)

1. Wolfson P, Abernethy D, DiPette DJ, Zusman R: Diltiazem and captopril alone or in combination for treatment of mild to moderate systemic hypertension. Am J Cardiol 1988;62(suppl):103G-108G.
2. Lang R, Degenhardt ST, Ollenschlager G, Barth A: Effect of a low-dose combination nitrendipine/enalapril in less-severe degrees of hypertension. J Cardiovasc Pharmacol 1987;9(suppl 4):S254-S255.
3. Felicetta JV, Serfer HM, Cutler NR, Comstock JT, Huber GL, Weir MR: A dose-response trial of once-daily diltiazem. Am Heart J 1992;123:1022-1026.
4. Chrysant SG, Brown RD, Kem DC, Brown JL: Antihypertensive and metabolic: effects of a new converting enzyme inhibitor, enalapril. Clin Pharmacol Ther 1983;33:741-746.
5. Lappe JT, Nelson EB, Makris L, Goldberg AI: Efficacy and safety of concomitant enalapril and diltiazem ER in patients with essential hypertension (abstract). Am J Hypertens 1993;6:117A.
6. Applegate WB, Cohen JD, Wolfson P, Davis A, Green S: Evaluation of blood pressure response to the combination of enalapril (single dose) and diltiazem ER (four different doses) in systemic hypretension. Am J Cardiol 1996;78:51-55.
7. Veterans Administration Cooperative Study Group on Antihypertensive Agents: Effects of treatment on morbidity in hypertension, I: results in patients with diastolic blood pressures averaging 115 through 129 mmHg. JAMA 1967;202(suppl):116-122.
8. Veterans Administration Cooperative Study Group on Antihypertensive Agents: Effects of treatment on morbidity in hypertension II: results in patients with diastolic blood pressure averaging 90 through 114 mmHg. JAMA 1970;213:1143-1152.
9. National High Blood Pressure Education Program: The Fifth Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Bethesda: US Department of Health and Human Services, National Heart, Lung, and Blood Institute. NIH publication no. 93-1088, January, 1993.
10. Pullar T, Birtwell AJ, Wiles PG, Hay A, Feely MP: Use of a pharmacologic indicator to compare compliance with tablets prescribed to be taken once, twice, or three times daily. Clin Pharmacol Ther 1988;44:540-545.
11. Cramer JA, Mattson RH, Prevey ML, Scheyer RD, Oulette VL: How often is medication taken when prescribed? A novel assessment technique. JAMA 1989;261:3272-3277.
12. Chrysant SG, Chappel C, Franham DJ, Levin B, Lueg M, McCluskey D, Steiner C: Antihypertensive and metabolic effects of single and combined atenolol regimens. J Clin Pharmacol 1992;32:61-65.
13. Chrysant SG: Antihypertensive effectiveness of low-dose lisinopril-hydrochlorothiazide combination: a large multicenter study. Arch Intern Med 1994;154:737-743.
14. Chrysant SG: Experience with terazosin administered in combination with other antihypertensive agents. Am J Med 1986; 80(5B).(suppl):55-61.
15. Chrysant SG, Bal IS, Johnson B, McPherson M: A comparative study of captopril and enalapril in patients with severe hypertension. J Clin Pharmacol 1985;25:149-151.
16. Chrysant SG, Chrysant C, Bal IS, Trus J, Hitchcock A: Treatment of severe hypertension with atenolol and betaxolol with once-daily regimens: hemodynamic aspects. Chest 1989;96:499-504.
17. Pieri R, Nardecchia A, Pirrelli A: Combined nifedipine and captopril treatment of moderately severe primary hypertension. Am J Nephrol 1986;6(suppl 1):111-114.
18. White WB, Viadero JJ, Lane TJ, Podesla S: Effects of combination therapy with captopril and nifedipine in severe or resistant hypertension. Clin Pharmacol Ther 1986;39:43-48.
19. Eggertsen R, Svensson A, Dahlof B, Hansson L: Additive effect of isradipine in combination with captopril in hypertensive patients. Am J Med 1989;86(4A),(suppl):124-126.
20. Gennari C, Nami R, Pavese G, Gragnani S, Bianchini C, Buracchi P: Calcium channel blockade (nitrendipine) in combination with ACE inhibition (captopril) in the treatment of mild to moderate hypertension. Cardiovasc Drug Ther 1989;3(suppl 1):319-325.
21. MacLean D: Combination therapy with amlodipine and captopril for resistant systemic hypertension. Am J Cordiol 1994: 73(suppl):55A-58A.
22. Jensen H, Garsdal P, Davies J: Amlodipine with enalapril therapy in moderate-severe essential hypertension. J Hum Hypertens 1990;4:541-545.